Hundreds of businesses and clinics in the United States are engaged in direct-to-consumer
marketing of unproven and unlicensed stem cell–based interventions. This essay provides …

Numerous US businesses that engage in direct-to-consumer advertising of stem cell
interventions that are not US FDA-approved also recruit clients by listing 'pay-to …

Background Cell therapies are an emerging form of healthcare that offer significant potential
to improve the practice of medicine and provide benefits to patients who currently have …

Thanks to the advantages of easy harvesting and escape from immune rejection, autologous
bone marrow‐derived mesenchymal stem cells (BMSCs) are promising candidates for …

Aim: This study examines marketing claims of Canadian businesses engaged in direct-to-
consumer advertising of putative stem cell treatments. Methods: Internet searches were used …

Type 1 diabetes mellitus (T1DM) is a form of early onset diabetes mellitus characterized by
the autoimmune destruction of insulin-producing cells (IPCs), resulting in hyperglycemia and …

The promise of cell and gene therapies is being realized as new products emerge to treat
diseases once considered intractable. These treatments are emerging amidst reports of …

Cell and tissue-based products, such as autologous adult stem cells, are being prescribed
by physicians across the world for diseases and illnesses that they have neither been …

The direct-to-consumer marketing of stem cells for unproven therapeutic uses has grown
rapidly in the United States in recent years. This development is surprising since the …

High-level quadriplegia is a devastating condition with limited treatment options. Bone
marrow derived stem cells (BMSCs) are reported to have immunomodulatory and …